Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-08-15 Purchase | 2022-08-17 4:45 pm | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 3,000 | $15.43 | $46,290 | 3,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-11 Exercise | 2024-10-15 4:53 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 8,222 | $0 | 33,366 (Direct) | View |
| 2024-10-11 Tax Withholding | 2024-10-15 4:53 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 2,066 | $6.63 | 33,366 (Direct) | View |
| 2024-10-03 Tax Withholding | 2024-10-07 9:30 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 4,177 | $7.83 | 43,793 (Direct) | View |
| 2024-10-03 Exercise | 2024-10-07 9:30 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 16,622 | $0 | 43,793 (Direct) | View |
| 2024-02-15 Option Award | 2024-04-24 10:16 am | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 7,083 | $0 | 14,765 (Direct) | View |
| 2023-10-11 Exercise(A) | 2024-04-22 08:37 am | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 8,221 | $0 | 28,034 (Direct) | View |
| 2022-10-11 Tax Withholding(A) | 2024-04-22 08:31 am | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 3,539 | $15.17 | 7,682 (Direct) | View |
| 2023-12-19 Option Award | 2024-02-21 6:24 pm | N/A 2026-12-19 | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 31,422 | $0 | 31,422 (Direct) | View |
| 2023-10-11 Tax Withholding | 2023-10-12 2:18 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 2,066 | $7.15 | 54,202 (Direct) | View |
| 2022-10-11 Exercise | 2023-10-12 2:18 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 22,597 | $0 | 54,202 (Direct) | View |
| 2023-10-03 Tax Withholding | 2023-10-06 2:47 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 4,117 | $7.06 | 50,432 (Direct) | View |
| 2023-10-03 Exercise | 2023-10-06 2:47 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 16,662 | $0 | 50,432 (Direct) | View |
| 2022-10-11 Tax Withholding | 2023-03-30 12:19 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 6,539 | $15.17 | 21,125 (Direct) | View |
| 2022-10-11 Exercise | 2023-03-30 12:19 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 8,221 | $0 | 21,125 (Direct) | View |
| 2022-10-03 Option Award | 2022-10-05 1:17 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward CFO/COO | 147,504 | $0 | 147,504 (Direct) | View |
| 2021-10-11 Option Award | 2021-10-13 4:45 pm | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward COO and CFO | 49,855 | $0 | 49,855 (Direct) | View |
Ownership | 2021-10-12 08:15 am | N/A N/A | OptimizeRx Corp | OPRX | Stelmakh Edward COO and CFO | 0 | $0 | 0 (Direct) | View |